Background: North American and European health agencies recently warned of severe
breathing problems associated with gabapentinoids, including in patients with chronic …

Background: Patients with chronic obstructive pulmonary disease (COPD) are commonly
treated with inhaled corticosteroid/long-acting ß2-agonist combination therapy. While …

Background/objective To compare the efficacy of budesonide/formoterol (BF) versus
fluticasone/salmeterol (FS) in patients with moderate-to-severe chronic obstructive …

La base del tratamiento de mantenimiento de la EPOC son los broncodilatadores de acción
larga y los corticoides inhalados. Frente a las modificaciones recientes en las guías de …

Background In primary care, identifying pneumonia events in people with chronic obstructive
pulmonary disease (COPD) may be challenging due to similarities in symptoms with COPD …

Triple therapy for chronic obstructive pulmonary disease (COPD) is recommended for some
patients, but the inhaled corticosteroids (ICS) may differ in effectiveness and safety. We …

To minimize clinical heterogeneity across COPD studies, we conducted two separate NMAs
[1, 2] and presented the data in parallel in the same journal. The dual therapy NMA [2] …

Decades of research have shown that the microbiome plays a fundamental role in how the
immune system develops and how inflammatory responses are shaped and regulated. The …

Objetivo el objetivo del estudio fue describir el perfil epidemiológico, clínico y calidad de
vida de los pacientes con enfermedad pulmonar obstructiva crónica, estables, en …

Introduction: Chronic Obstructive Pulmonary Disease (COPD) is a highly prevalent condition
in the United States (US). Among individuals with moderate to very severe COPD, inhalation …